デフォルト表紙
市場調査レポート
商品コード
1403764

化粧品ペプチド合成の世界市場 (~2033年):用途・エンドユーザー別の市場規模・地域的展望・競合戦略・セグメント予測

Cosmetics Peptide Synthesis Market Size- By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 235 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
化粧品ペプチド合成の世界市場 (~2033年):用途・エンドユーザー別の市場規模・地域的展望・競合戦略・セグメント予測
出版日: 2023年12月29日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 235 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の化粧品ペプチド合成の市場規模は、予測期間中に5.79%のCAGRで成長すると予測されています。

当レポートでは、世界の化粧品ペプチド合成の市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 促進要因・制約・機会・課題の分析
  • COVID-19による市場への影響

第5章 市場変数と見通し

  • SWOT分析
  • PESTEL分析
  • ポーターの分析
  • ヒートマップ分析

第6章 競合情勢

  • 製造拠点の分布・販売エリア・製品タイプ
  • M&A・提携・製品発売・協力

第7章 世界の化粧品ペプチド合成市場:用途別

  • 市場規模のシェア・予測
  • 色素沈着防止
  • 老化防止
  • アイケア

第8章 世界の化粧品ペプチド合成市場:エンドユーザー別

  • 市場規模のシェア・予測
  • 学術研究機関
  • 受託開発製造機構 (CDMO)
  • CRO・CMO向けのペプチド合成市場
  • 製薬・バイオテクノロジー企業

第9章 世界の化粧品ペプチド合成市場の予測

  • 市場規模・市場シェア

第10章 世界の化粧品ペプチド合成市場:用途別

  • 市場規模・市場シェアの推移・予測

第11章 世界の化粧品ペプチド合成市場:エンドユーザー別

  • 市場規模・市場シェアの推移・予測

第12章 世界の化粧品ペプチド合成市場:地域別

  • 市場規模・市場シェアの推移・予測
  • アジア太平洋
  • 欧州
  • 中東・アフリカ
  • 北米
  • ラテンアメリカ

第13章 企業プロファイル

  • AAPPTec
  • Bachem Holding AG
  • Bio Basic Inc.
  • Biopeptide Co., Ltd.
  • Creative Peptides
  • GenScript Corp.
  • Pentapharm Ltd
  • Peptech Laboratories, Inc.
  • Peptide Technologies Ltd
  • RS Synthesis, LLC
  • その他

第14章 略語のリスト

第15章 参考リンク

第16章 総論

第17章 調査範囲

目次
Product Code: FMCG23165

Cosmetics Peptide Synthesis Market Introduction and Overview

According to SPER Market Research, 'Cosmetics Peptide Synthesis Market Size- By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Cosmetics Peptide Synthesis Market is predicted to reach with a CAGR of 5.79%.

A peptide is a brief sequence of two to fifty amino acids that are joined by a covalent bond during a condensation process. Peptides give stem cells life. Subsequently, these cells divide to generate more stem cells (a process called self-renewal) or specialised cells, including skin cells (a process called differentiation). Peptides have the power to regenerate skin cells at the cellular level, which leads to better-looking, firmer, tauter skin with less wrinkles and laughing lines.

Cosmetic peptide synthesis eventually suffered from the COVID-19 pandemic's short-term detrimental impact on the cosmetics industry. Given that customers would be more interested in personal hygiene products in 2021 due to COVID-19's impact on the cosmetics industry, the market for cosmetics would likely shrink dramatically. Although the majority of participants said they didn't spend much money on their personal lifestyle choices, those who had serious dysmorphic worries continued to feel self-conscious about their looks.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2033

Base year considered 2022

Forecast period 2023-2033

Segments covered By Application, By End User

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered AAPPTec, Bachem Holding AG, Bio Basic Inc., Biopeptide Co., Ltd., Creative Peptides, GenScript Corp., Pentapharm Ltd, Peptech Laboratories, Inc., Peptide Technologies Ltd, RS Synthesis, LLC.

Cosmetics Peptide Synthesis Market Segmentation:

By Application: Based on the Application, Global Cosmetics Peptide Synthesis Market is segmented as; Anti Pigmentation, Anti-Aging, Eye Care.

By End-User: Based on the End-User, Global Cosmetics Peptide Synthesis Market is segmented as; Academic and Research Institutes, Contract Development and Manufacturing Organization (CDMO), Peptide Synthesis Market for CRO & CMO, Pharmaceutical and Biotechnology Companies.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Cosmetics Peptide Synthesis Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Cosmetics Peptide Synthesis Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cosmetics Peptide Synthesis Market

7. Global Cosmetics Peptide Synthesis Market, By Application (USD Million)

  • 7.1. Global Cosmetics Peptide Synthesis Market Value Share and Forecast, By Application, 2023-2033
  • 7.2. Anti Pigmentation
  • 7.3. Anti-Aging
  • 7.4. Eye Care

8. Global Cosmetics Peptide Synthesis Market, By End User (USD Million)

  • 8.1. Global Cosmetics Peptide Synthesis Market Value Share and Forecast, By End User, 2023-2033
  • 8.2. Academic and Research Institutes
  • 8.3. Contract Development and Manufacturing Organization (CDMO)
  • 8.4. Peptide Synthesis Market for CRO & CMO
  • 8.5. Pharmaceutical and Biotechnology Companies

9. Global Cosmetics Peptide Synthesis Market Forecast, 2019-2033 (USD Million)

  • 9.1. Global Cosmetics Peptide Synthesis Market Size and Market Share

10. Global Cosmetics Peptide Synthesis Market, By Application 2019-2033 (USD Million)

  • 10.1. Global Cosmetics Peptide Synthesis Market Size and Market Share By Application (2019-2026)
  • 10.2. Global Cosmetics Peptide Synthesis Market Size and Market Share By Application (2027-2033)

11. Global Cosmetics Peptide Synthesis Market, By End User, 2019-2033 (USD Million)

  • 11.1. Global Cosmetics Peptide Synthesis Market Size and Market Share By End User (2019-2026)
  • 11.2. Global Cosmetics Peptide Synthesis Market Size and Market Share By End User (2027-2033)

12. Global Cosmetics Peptide Synthesis Market, By Region, 2019-2033 (USD Million)

  • 12.1. Global Cosmetics Peptide Synthesis Market Size and Market Share By Region (2019-2026)
  • 12.2. Global Cosmetics Peptide Synthesis Market Size and Market Share By Region (2027-2033)
  • 12.3. Asia-Pacific
    • 12.3.1. Australia
    • 12.3.2. China
    • 12.3.3. India
    • 12.3.4. Japan
    • 12.3.5. South Korea
    • 12.3.6. Rest of Asia-Pacific
  • 12.4. Europe
    • 12.4.1. France
    • 12.4.2. Germany
    • 12.4.3. Italy
    • 12.4.4. Spain
    • 12.4.5. United Kingdom
    • 12.4.6. Rest of Europe
  • 12.5. Middle East and Africa
    • 12.5.1. Kingdom of Saudi Arabia
    • 12.5.2. United Arab Emirates
    • 12.5.3. Rest of Middle East & Africa
  • 12.6. North America
    • 12.6.1. Canada
    • 12.6.2. Mexico
    • 12.6.3. United States
  • 12.7. Latin America
    • 12.7.1. Argentina
    • 12.7.2. Brazil
    • 12.7.3. Rest of Latin America

13. Company Profile

  • 13.1. AAPPTec
    • 13.1.1. Company details
    • 13.1.2. Financial outlook
    • 13.1.3. Product summary
    • 13.1.4. Recent developments
  • 13.2. Bachem Holding AG
    • 13.2.1. Company details
    • 13.2.2. Financial outlook
    • 13.2.3. Product summary
    • 13.2.4. Recent developments
  • 13.3. Bio Basic Inc.
    • 13.3.1. Company details
    • 13.3.2. Financial outlook
    • 13.3.3. Product summary
    • 13.3.4. Recent developments
  • 13.4. Biopeptide Co., Ltd.
    • 13.4.1. Company details
    • 13.4.2. Financial outlook
    • 13.4.3. Product summary
    • 13.4.4. Recent developments
  • 13.5. Creative Peptides
    • 13.5.1. Company details
    • 13.5.2. Financial outlook
    • 13.5.3. Product summary
    • 13.5.4. Recent developments
  • 13.6. GenScript Corp.
    • 13.6.1. Company details
    • 13.6.2. Financial outlook
    • 13.6.3. Product summary
    • 13.6.4. Recent developments
  • 13.7. Pentapharm Ltd
    • 13.7.1. Company details
    • 13.7.2. Financial outlook
    • 13.7.3. Product summary
    • 13.7.4. Recent developments
  • 13.8. Peptech Laboratories, Inc.
    • 13.8.1. Company details
    • 13.8.2. Financial outlook
    • 13.8.3. Product summary
    • 13.8.4. Recent developments
  • 13.9. Peptide Technologies Ltd
    • 13.9.1. Company details
    • 13.9.2. Financial outlook
    • 13.9.3. Product summary
    • 13.9.4. Recent developments
  • 13.10. RS Synthesis, LLC
    • 13.10.1. Company details
    • 13.10.2. Financial outlook
    • 13.10.3. Product summary
    • 13.10.4. Recent developments
  • 13.11. Others

14. List of Abbreviations

15. Reference Links

16. Conclusion

17. Research Scope